<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02660463</url>
  </required_header>
  <id_info>
    <org_study_id>CTEPH-2016</org_study_id>
    <nct_id>NCT02660463</nct_id>
  </id_info>
  <brief_title>Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany</brief_title>
  <official_title>Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kerckhoff Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kerckhoff Klinik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after acute pulmonary
      embolism ist not clear. It is estimated to be up to 3.8%. Prospective data registration does
      not exist. Treatment of choice is pulmonary endarterectomy if the thromboembolic lesions are
      surgically accessible. Otherwise interventional therapy by means of pulmonary
      balloon-angioplasty (BPA) or medical therapy is indicated. In Germany, the majority of the
      patients is referred to three CTEPH centers: Kerckhoff Clinic, Saarland University Hospital
      and Hannover Medical School to evaluate the therapeutic options. Starting in January 2016 all
      incident patients will be de-identified and included prospectively. Risk factors, outcome and
      treatment will be documented.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients referred to the participating centers will be diagnosed in a standardized manner
      to confirm the diagnosis &quot;CTEPH&quot;. No additional intervention or blood sampling is necessary.
      The recommended treatment option is the result of weekly CTEPH conferences. Every patient
      will be discussed.

      The registry contains the following data:

      Center PLZ Sex Age Body Mass Index History of venous thromboembolism (VTE), Date ff 1st VTE
      Anticoagulation and type of anticoagulation Blood group V/Q scan CT-agiography Pulmonary
      angiogram World Health Organisation-Functional Class six-minute walk distance Right heart
      catheter: RAP, PAPs, PAPd, PAPm, PAWP, CO, CI, PVR, SvO2 Treatment: PEA, Ballon Pulmonary
      Angioplasty (BPA), medically therapy, Vena cava filter CTEPH special risk factors:
      thrombophilia, antiphospholipid antibody syndrome, splenectomy, VA shunt; pacemakers
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>30 Days</target_duration>
  <primary_outcome>
    <measure>Diagnosis &quot;CTEPH&quot; confirmed</measure>
    <time_frame>12 months</time_frame>
    <description>Aim of the study is to detect prospectively the incidence of the diagnosis CTEPH during one year in Germany.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment</measure>
    <time_frame>12 months</time_frame>
    <description>Registration of the frequency of different treatment options, e.g. pulmonary endarterectomy, pulmonary ballon-angioplasty and medical therapy</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>CTEPH</condition>
  <condition>Chronic Thromboembolic Pulmonary Hypertension</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registration of the diagnosis &quot;CTEPH&quot;</intervention_name>
    <description>Registration of risk factors for thromboembolic events</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient with confirmed CTEPH during the year 2016 or not diagnosis confirmation not
        more than 6 months ago
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis &quot;CTEPH&quot; confirmed

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eckhard Mayer, Prof. Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Kerckhoff Klinik, Bad Nauheim, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thorsten Kramm, Dr.</last_name>
    <phone>+49 6032 996 2402</phone>
    <email>t.kramm@kerckhoff-klinik.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Guth, Dr.</last_name>
    <phone>+49 6032 996 2402</phone>
    <email>s.guth@kerckhoff-klinik.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kerckhoff Clicic</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Kramm, Dr.</last_name>
      <phone>+49 6032 996 2402</phone>
      <email>t.kramm@kerckhoff-klinik.de</email>
    </contact>
    <contact_backup>
      <last_name>Stefan Guth, Dr.</last_name>
      <phone>+49 6032 996 2402</phone>
      <email>s.guth@kerckhoff-klinik.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marius Hoeper, MD PhD</last_name>
      <phone>+49 511 5323530</phone>
      <email>hoeper.marius@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Karen Olsson, MD</last_name>
      <phone>+49 511 5323530</phone>
      <email>olsson.karen@mh-hannover.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>https://www.cteph-association.org/registries/new-cteph-database/</url>
    <description>International CTEPH Association - The new CTEPH registry</description>
  </link>
  <reference>
    <citation>Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Goldsmith K, Coghlan JG, Pepke-Zaba J. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009 Feb;33(2):332-8. doi: 10.1183/09031936.00092008. Epub 2008 Oct 1.</citation>
    <PMID>18829679</PMID>
  </reference>
  <reference>
    <citation>Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7. doi: 10.1164/rccm.200712-1841OC. Epub 2008 Feb 21.</citation>
    <PMID>18292468</PMID>
  </reference>
  <reference>
    <citation>McGoon MD, Benza RL, Escribano-Subias P, Jiang X, Miller DP, Peacock AJ, Pepke-Zaba J, Pulido T, Rich S, Rosenkranz S, Suissa S, Humbert M. Pulmonary arterial hypertension: epidemiology and registries. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9. doi: 10.1016/j.jacc.2013.10.023. Review.</citation>
    <PMID>24355642</PMID>
  </reference>
  <results_reference>
    <citation>Wilkens H, Lang I, Behr J, Berghaus T, Grohe C, Guth S, Hoeper MM, Kramm T, Krüger U, Langer F, Rosenkranz S, Schäfers HJ, Schmidt M, Seyfarth HJ, Wahlers T, Worth H, Mayer E. Chronic thromboembolic pulmonary hypertension (CTEPH): updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol. 2011 Dec;154 Suppl 1:S54-60. doi: 10.1016/S0167-5273(11)70493-4.</citation>
    <PMID>22221974</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2016</study_first_posted>
  <last_update_submitted>January 20, 2016</last_update_submitted>
  <last_update_submitted_qc>January 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kerckhoff Klinik</investigator_affiliation>
    <investigator_full_name>Dr. Thorsten Kramm</investigator_full_name>
    <investigator_title>Dr. Thorsten Kramm, M.D.</investigator_title>
  </responsible_party>
  <keyword>incidence</keyword>
  <keyword>risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

